MALAT1 and nasopharyngeal carcinoma: Such as the lncRNA MALAT1, it can be used as a competitive endogenous RNA (ceRNA) to competitively sponge with miR-124, thus releasing the inhibited target Capn4, which promotes the progress of NPC by reducing the expression of E-cadherin and increasing the expression of N-cadherin and vimentin45.